Ali El‐Ali

Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion‐dependent thalassaemia

John B. Porter, Mohsen Saleh Elalfy, Alì Taher et al. · European Journal Of Haematology · 2016 · 40 citations · Full text

Medicine, Hematology, Radiology +17

Importance of optimal dosing ≥30 mg/kg/d during deferasirox treatment: 2.7‐yr follow‐up from the ESCALATOR study in patients with β‐thalassaemia

Alì Taher, Mohsen Saleh Elalfy, Kusai Al Zir et al. · European Journal Of Haematology · 2011 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment

John B. Porter, Mohsen Saleh Elalfy, Vip Viprakasit et al. · European Journal Of Haematology · 2015 · 31 citations

Medicine, Hematology, Hematopathology +16